Merdad Parsey, the Chief Medical Officer of $GILD ($GILD), sold 3,199 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.4% of their shares. Following this trade, they now own 91,200 shares of $GILD stock.
$GILD Insider Trading Activity
$GILD insiders have traded $GILD stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $GILD stock by insiders over the last 6 months:
- MERDAD PARSEY (Chief Medical Officer) has traded it 10 times. They made 0 purchases and 10 sales, selling 215,047 shares.
- JEFFREY BLUESTONE sold 6,788 shares.
- JOHANNA MERCIER (Chief Commercial Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 49,360 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GILD Hedge Fund Activity
We have seen 766 institutional investors add shares of $GILD stock to their portfolio, and 916 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 14,680,161 shares (+79.4%) to their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP added 11,665,593 shares (+50.9%) to their portfolio in Q3 2024
- PACER ADVISORS, INC. removed 7,108,073 shares (-90.1%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC added 4,739,526 shares (+1702.5%) to their portfolio in Q3 2024
- TWO SIGMA ADVISERS, LP removed 3,767,900 shares (-60.2%) from their portfolio in Q3 2024
- TWO SIGMA INVESTMENTS, LP removed 2,634,933 shares (-79.0%) from their portfolio in Q3 2024
- D. E. SHAW & CO., INC. removed 2,597,051 shares (-77.8%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
